Safety and Efficacy of THN102 in Patients With Parkinson's Disease and Excessive Daytime Sleepiness
Thématique(s) / pathologie(s)
- Maladie de Parkinson
Objectifs
Plus d'informations disponibles sur : https://clinicaltrials.gov/ct2/show/NCT03624920?term=theranexus&cond=Parkinson&draw=2&rank=1
Promoteur
Theranexus
Investigateur
Pr Jean-Christophe Corvol
Publication(s) scientifique(s)
-
Corvol JC et al. THN 102 for Excessive Daytime Sleepiness Associated with Parkinson's Disease: A Phase 2a Trial. Mov Disord. 2021 Oct 28.
Statut
Résultats publiés
